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Abstract
Respiratory syncytial virus (RSV) causes recurrent infections throughout life. Vaccine development may depend upon
understanding the molecular basis for induction of ineffective immunity. Because dendritic cells (DCs) are critically involved
in early responses to infection, their interaction with RSV may determine the immunological outcome of RSV infection.
Therefore, we investigated the ability of RSV to infect and activate primary mDCs and pDCs using recombinant RSV
expressing green fluorescent protein (GFP). At a multiplicity of infection of 5, initial studies demonstrated ,6.8% of mDC1
and ,0.9% pDCs were infected. We extended these studies to include CD1c
2CD141
+ mDC2, finding mDC2 infected at
similar frequencies as mDC1. Both infected and uninfected cells upregulated phenotypic markers of maturation. Divalent
cations were required for infection and maturation, but maturation did not require viral replication. There is evidence that
attachment and entry/replication processes exert distinct effects on DC activation. Cell-specific patterns of RSV-induced
maturation and cytokine production were detected in mDC1, mDC2, and pDC. We also demonstrate for the first time that
RSV induces significant TIMP-2 production in all DC subsets. Defining the influence of RSV on the function of selected DC
subsets may improve the likelihood of achieving protective vaccine-induced immunity.
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Introduction
Respiratory syncytial virus (RSV) is a pneumovirus in the family
Paramyxoviridae and has a non-segmented negative-sense single-
stranded RNA genome [1]. RSV is a major cause of respiratory
disease in infants, the elderly, and recipients of bone marrow or
lung transplants. Infants who experience severe disease are at
significant risk for development of wheezing and hyperreactive
airways disease in later childhood [2–4]. More than 95% of
children are infected with RSV by 2 years of age, and ,50% of
children infected in the first year of life are reinfected during the
second year [5]. Therefore, natural RSV infection fails to induce
immunity that prevents reinfection despite relatively minor genetic
variation between strains [6,7]. Inefficient function in memory T
and B cell compartments has been described [8–11], and adults
are reinfected throughout life. Approximately 25% of healthy
adults repeatedly challenged intranasally with the identical strain
of RSV could be reinfected [7]. Reinfection during childhood
causes significant morbidity [12], and in adults with normal
immune function, symptoms are typically restricted to the upper
airway. Antibody responses induced by natural infection in infants
have been reported to be of relatively low magnitude and short-
lived [13], but when the titers of pre-existing maternal antibody
are low, infection-induced antibodies are generally sufficient to
protect the lower respiratory tract [14]. RSV is also known to
suppress the proliferative capacity of lymphocytes [15]. Thus,
there is evidence that RSV interferes with development of both
humoral and cell-mediated immune mechanisms which results in
an overall immunological state that cannot protect the upper
airway from reinfection.
Two distinctive features of the immune response to RSV,
allergic Th2-biased inflammation associated with severe neonatal
disease and failure to induce protective immunity, suggest
induction of inappropriate and ineffective RSV-specific immune
responses occurs at the time of initial antigen exposure. Dendritic
cells (DCs) may represent the earliest encounter between the virus
and the host immune system. Distributed at mucosal surfaces (i.e.
portals of entry) and throughout the body in organs and blood,
DCs serve as professional antigen-presenting cells (APCs). DCs are
organized into phenotypic and functional subsets [16]. The two
major classes are CD11c
+ myeloid DCs (mDCs) and CD11c
2
plasmacytoid DCs (pDCs) with distinct and complementary roles
in the induction of immune responses. Additional distinctions can
be made within the mDC subset with recent identification of
CD1c
2CD141
+ DCs, termed mDC2, while the prototypic mDC,
now designated mDC1, are CD1c
+CD141
2 [17–20]. mDCs are
efficient in uptake, processing, and presentation of foreign antigens
while pDCs are less effective in these processes. Upon encounter
with antigen, both mDCs and pDCs undergo maturation,
upregulating CD80, CD83, CD86, CD40, and major histocom-
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activation. Upon contact with antigen, DCs are activated to
secrete an array of cytokines and chemokines. This is of particular
importance to antiviral immunity as pDCs can be triggered to
produce high levels of type I interferons upon exposure to virus
[21–25]. Secretion of IFN-a has been suggested as an important
factor to subsequent maturation of mDCs [21,22,24]. This division
of labor may be of special significance at mucosal sites such as the
lung as recently reviewed [26]. RSV has evolved multiple
mechanisms to interfere with induction and effector functions of
type I interferons [1]. The nonstructural (NS) proteins 1 and 2 are
first in the gene order, signifying their importance, and appear to
be entirely devoted to the inhibition of IFN pathways [27].
Monocytes isolated from neonates or from adults exhibit
markedly different cytokine profiles following exposure to RSV
with monocytes from adults producing high levels of cytokines
associated with innate and adaptive immunity [28]. In contrast,
neonatal monocytes produced a more limited set of cytokines and
did not proliferate following RSV exposure, suggesting suppression
of adaptive immunity in neonates may contribute to RSV-induced
disease in early life. Similarly, RSV has been shown to infect cord
blood-derived DCs, increasing surface expression of maturation
markers and cytokine production [29,30]. Furthermore, RSV-
infected cord-blood DCs co-cultured with autologous T cells
induced T cell proliferation, but suppressed T cell-derived IFN-c
production [30–32].
Most studies examining RSV interactions with human DCs
have been conducted using monocyte-derived DCs (moDCs)
generated in vitro from adult peripheral blood monocytes. As with
cord-blood derived DCs, RSV was shown to infect and mature
moDCs [33–36]. When co-cultured with autologous T cells, RSV-
exposed moDCs suppressed cytokine production and T cell
proliferation [33,34,36–38]. The age of the DC donor was shown
to influence the magnitude of T cell suppression [38]. Type 2
cytokine production could be suppressed without concomitant
induction of type 1 cytokine production [33]. Chi et. al.
demonstrated IFN-a and IFN-l in supernatants from moDCs
suppressed proliferation of CD4 T cells [37]. When exposed to
recombinant RSV having deletions of NS1, alone or in
conjunction with NS2, the percentage of RSV-infected moDCs
were reduced, but cytokine production and expression of selected
maturation markers were increased [39]. Antibody blocking of the
type I IFN receptor increased the number of RSV-infected
moDCs, but inhibited maturation, leading the authors to suggest
that NS1 and NS2 proteins suppress moDC maturation by
antagonism of type 1 IFNs. In addition to maturation markers,
RSV infection selectively increased expression of ligands for NK
cell receptors, demonstrating the potential for RSV to regulate
innate immunity [40].
Primary DCs have also been studied in human, bovine, and
ovine RSV infection. RSV infection has been shown to induce
infiltration of mDCs and pDCs and cytokine production in the
respiratory tract of children during acute infection with concom-
itant decreases of both cell types in the blood [41,42]. Influenza
also increased DC recruitment and cytokine levels in this study,
but greater numbers of mDC1 and pDC2 in the respiratory tract
and higher levels of MCP-1 in the nasal wash and RANTES in the
serum in influenza-infected infants suggested that RSV and
influenza induce distinct patterns of innate immune responses
[41]. DC numbers in the blood of children at age 6 yrs who were
hospitalized with bronchiolitis during primary RSV infection
demonstrated that those children diagnosed with asthma by age 6
had fewer mDCs and pDCs than did non-asthmatic study
participants with greater deficits found in pDC numbers [43]. A
limited number of ex vivo studies examining the effects of RSV
exposure on primary pDCs have been performed [44,45],
demonstrating that RSV Long induces IFN-a production [44]
while RSV A2 appears to inhibit IFN-a production mediated by
TLR7 [45]. Similarly, preexposure of pDCs to RSV reduced
production of IFN-a elicited by TLR3 or TLR9 agonists [34].
While present at a much lower frequency than mDC1 and pDC
in the circulation [19,20], mDC2 are found in the lung at a 2–3-
fold greater frequency than mDC1 and 3–6-fold greater frequency
than pDC [46,47]. The identification of numerous phenotypic and
functional differences among pulmonary mDC2 and mDC1 or
pDC suggests a possible preferential role for mDC2 in generating
or regulating immunity and disease pathogenesis in the respiratory
tract distinct from that of mDC1 and pDC [46,48]. The case for
distinct roles in host immunity for each human DC subset is
further strengthened by recent publications from four independent
labs showing human CD141+ mDC2 are the functional equivalent
of mouse CD8a+ DCs, capable of cross-presentation of exogenous
antigens [49–53]. Furthermore, the increased frequency of mDC2
in the circulation of children with acute asthma [54] makes
interactions between RSV and mDC2 of particular interest. Here
we examine the effects of exposure to RSV on primary mDCs and
pDCs, in parallel with moDCs and macrophages derived in vitro
from monocytes from the same donor, using recombinant RSV A2
expressing GFP (rgRSV). Incorporating rgRSV into a multipa-
rameter flow cytometry panel allows simultaneous analyses of
infection rate, viability, and 4–8 additional cellular factors, such as
maturation markers, on a single cell basis. Using this experimental
system, we evaluated the impact of RSV exposure on the infection
and maturation of DCs and demonstrate that mDC1 and mDC2
are infected at similar levels, and at a rate about 5-fold higher than
pDC. In addition, we describe the patterns of maturation and
cytokine production in mDC1, mDC2, and pDC compared to
moDCs and macrophages. This is the first detailed analyses of the
impact of RSV exposure on primary human myeloid dendritic
cells and provides a benchmark for future studies on the impact of
RSV on dendritic cell function.
Materials and Methods
Viruses
Recombinant RSV expressing GFP (rgRSV), a gift of Mark
Peeples (Ohio State University) [55] was grown in HEp-2 cells
with MEM containing 10% FCS. To remove cytokines produced
by HEp-2 cells (purchased from the American Type Culture
Collection) during growth of the virus stock, sucrose-purified
rgRSV stocks were. rgRSV was UV-inactivated by exposing virus
to 75,000 mJ/cm2 of ultraviolet light using a StrataLinker
(Stratagene). As a mock-infection control, uninfected HEp-2 cells
were processed in the same manner as done for RSV stocks.
Isolation of primary DCs and generation of moDCs and
macrophages
Elutriated human monocytes were obtained from the NIH
Department of Transfusion Medicine. Blood samples were
obtained from paid healthy volunteers who gave written informed
consent to participate in a study for the collection of blood samples
for in vitro research use approved by the National Cancer Institute
Central Institutional Review Board. The protocol is designed to
protect subjects from research risks as defined in 45CFR46 and to
abide by all NIH guidelines for human subjects research (protocol
number 99-CC-0168). The donors, who remained anonymous to
the investigators, were healthy adults of known age, gender, race,
and serologic status for HIV-1 and cytomegalovirus (CMV).
RSV Infection and Activation of Human Primary DCs
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BDCA-4, BDCA-1, then BDCA-3 magnetic isolation kits
(Miltenyi Biotec). Isolated pDCs were incubated in 10% RPMI
and IL-3 (1 ng/ml, BioWhittaker). Isolated mDC1 and mDC2
were cultured in 10% RPMI and GM-CSF (2 ng/ml, PeproTech
Inc.). Purity of the isolated DCs was examined by phenotypic
analyses using a lineage cocktail (CD3, CD14, CD16, CD19,
CD20, CD56), and CD1c, CD11c, CD14, CD123, and CD141
(BD Biosciences). The cells were rested at 37uC overnight.
Differences in basic phenotype and functional characteristics of
mDC1, mDC2, and pDC are listed in Table S1.
In initial studies, moDCs and macrophages were generated by
IL-4 and GM-CSF (1 mg/ml) treatment of remaining monocytes
following DC isolation. Monocytes were cultured with conditioned
medium from KPB-M15 cells, (a gift of Atsunobu Hiraoka, Osaka
Dental University, Osaka, Japan) to generate macrophages
[56].
Infection and maturation of DCs
Aliquots of isolated DCs and in vitro-derived moDCs and
macrophages (after 7–10 days culture) were exposed to rgRSV.
Mock-infected cells were exposed to the same dilution of mock
HEp-2 supernatant as used for rgRSV-infected samples. Twenty-
four hours post-infection (pi), cells were pelleted, and the
supernatants removed and frozen. The cells were stained, fixed
in 2% paraformaldehyde and analyzed by flow cytometry.
Requirements for divalent cations in RSV infection were
examined after EDTA treatment of rgRSV on ice for 30 minutes.
DCs were similarly treated with EDTA (30 min room tempera-
ture). rgRSV and DCs were then mixed, incubated, and analyzed
24 hr pi. To examine DC maturation, mDCs and pDCs exposed
to rgRSV (live, sucrose purified, UV-inactivated, or EDTA-
treated) for 24 hrs were stained with the premixed ‘‘DC activation
reagent’’ (BD Biosciences), fixed, and analyzed on the FACSCa-
libur flow cytometer. To evaluate DC maturation in greater detail,
a multiparameter flow cytometry panel was developed. RSV-
exposed DCs were stained with ViViD viability dye (Molecular
Probes) while incubating with Fc block (BD Biosciences), followed
by staining with a mixture of phenotypic and maturation cell
surface markers. After staining, cells were fixed and analyzed on
the LSRII flow cytometer (BD Biosciences). The antibody panels
are detailed in Table S2. Flow cytometry data were analyzed using
FlowJo software (Tree Star, Inc). Due to donor-to-donor variation
in receptor expression levels, mean fluorescence intensities (MFI)
for RSV-exposed samples were normalized to mock-infected
samples for the same donor to determine the fold-increase in
receptor expression. The normalized data from pooled donors
were then compared.
Cytokine and chemokine production
Cytokine and chemokine concentrations in the reserved DC
supernatants were measured by ELISA according to kit protocols
(R&D Systems). Multiplex cytokine and chemokine analyses were
performed on reserved DC supernatants by Aushon Biosystems,
Inc. (Billerica, MA). Due to donor-to-donor variation, cytokine
and chemokine concentrations (in pg/ml) for RSV-exposed
samples were normalized to mock-infected samples for the same
donor to determine the fold-increase in protein production. When
mock-treated samples were below the level of detection, the
protein concentration designated as the limit of detection (as
established by the manufacturer’s kit protocols) was used for
normalization. The normalized data from pooled donors were
then compared.
Statistical Analyses
Statistical comparisons were performed using SigmaStat
software. Wilcoxon rank sum analysis of variance was used to
determine statistical differences, with significant differences
defined where p,0.05. For correlation analyses, Spearman’s rank
order test was performed. Strong correlations are defined as
p,0.01, and weak correlations are defined as 0.01,p,0.05 while
positive correlations are demonstrated with r.0 and negative
(inverse) correlations with r,0.
Results
RSV infects a subset of primary mDC1 and pDCs
We first determined optimal conditions for RSV infection of
primary DCs. Isolated mDC1 and pDCs were infected with
varying doses of rgRSV (moi=1, 3, 5, 10) for 24 hrs. Maximal
infection occurred at moi=5 and did not increase at moi.5 (data
not shown). To optimize the kinetics of infection, mDC1 and
pDCs were infected with rgRSV (moi=5), and aliquots of infected
cells were analyzed at 0.5, 1, 2, 4, 6, 8, 18–24 (overnight), 48, and
72 hrs post-infection (pi). No infected cells were observed prior to
18–24 hr pi, and the percentage of infected cells did not
appreciably increase at 48 or 72 hrs pi (data not shown).
Therefore, DC infection and maturation were examined after
overnight incubation with RSV (moi=5). Examination of multiple
donors demonstrated that in all donors only a subset of mDC1 and
pDCs could be infected by rgRSV (Figure 1A). On average
6.863.9% of mDC1 (n=28 donors, p,0.0001) and 0.961.3% of
pDCs (n=20 donors, p=0.007) were infected with rgRSV at
24 hr pi.
Identification of new phenotypic markers allows the continued
division of DCs into functionally distinct subsets, as evidenced by
the recent separation of CD11c
+ mDCs into mDC1 and mDC2
subsets [17–20]. Phenotypic and functional markers of mDC1,
mDC2, and pDCs are summarized in Table S1. mDC1 and pDCs
represent ,1–3% of cells in the elutriated monocyte fraction while
mDC2 are much less frequent with the median mDC2 frequency
,0.3% (Figure 1B). When infection rates were evaluated in a
second cohort of donors, mDC1 and mDC2 infection rates were
similar and significantly higher than infection rates in pDCs
(Figure 1C).
RSV exposure increases expression of maturation
markers on mDCs and pDCs
Maturation of DCs following exposure to antigenic stimuli
results in the upregulation of a number of cell surface proteins.
Following RSV infection, expression of CD83, CD86, and, to a
lesser extent, CD209 was observed in RSV-infected mDC1
(Figure 2A). The pooled data from 16 mDC1 samples and 8
pDC samples are shown in Figures 2B with each sample obtained
from a different donor. While maturation of pDCs was also
induced, the magnitude of increased receptor expression was
markedly lower than that seen in mDC1 from the same donor.
Notably, maturation was induced in both rgRSV-infected and
rgRSV–uninfected DCs. This pattern was observed in all donors
to varying degrees. DC maturation was due directly to RSV and
not other soluble factors (e.g. cytokines) in the viral stock as
sucrose-purified virus induced similar levels of DC maturation
(data not shown). In pilot studies, we also evaluated mDC1
maturation in comparison to moDC and macrophages differen-
tiated in vitro using monocytes from the same donor (Figure 2C).
CD86 and CD40 expression were upregulated to greater extents
in moDCs than observed in macrophages or mDC1 (Figure 2C).
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mDC1, mDC2, and pDCs
In the second donor cohort, maturation of each DC subset was
assessed by expression of CD86, CD40, and CD209 following RSV
infection. When all cells in the culture were examined, expression of
CD86 in RSV-exposed mDC1, mDC2, and pDC was significantly
greater than in mock-infected cells (Figure 3A, p=0.005, p=0.04,
and p=0.001 for mDC1, mDC2, and pDC, respectively). In
contrast, RSV exposure induced little to no increase in CD40 or
CD209 expression in the total mDC1, mDC2, or pDC samples
(Figure 3A). When expression of maturation markers on RSV-
infected (i.e. GFP+) cells was examined (Figure 3B), CD86, CD40,
and CD209 upregulation on mDC1 was similar to levels seen in the
total RSV-exposed mDC1 pool while CD86 levels on GFP+ mDC2
weresignificantly lower than levels in the RSV-exposed total culture
(p=0.026). In contrast, CD86, CD40, and CD209 expression on
RSV-infected pDCs was greater than on the total pDC pool with
the differences in CD86 and CD40 levels attaining statistical
significance (p=0.01 and p=0.049, respectively). pDCs express
lower cell-surface levels of C-type lectins and, therefore, may not be
as susceptible to the effects of RSV binding alone in the absence of
productive infection. Actual maturation levels (i.e. non-normalized
MFIs) onuninfectedand infected cells foreach donoraredetailed in
Table S3.
RSV maturation requires cell surface interaction but not
infection
The ability of rgRSV to infect mDC1 (Figure 4) and pDCs (data
not shown) was abrogated by pretreatment of the cells or virus
with EDTA (Figure 4C) or by UV irradiation of the virus
(Figure 4D). Dose response studies demonstrated partial inhibition
of infection in the presence of 0.01 M EDTA and full inhibition at
0.05 M EDTA (data not shown). Thus, regardless of the amount
of virus used, only a subset of DCs can be infected with RSV, and
infection requires the presence of divalent cations. The ability of
EDTA treatment to block RSV-induced DC maturation suggests
that binding of viral particles to C-type lectins on the cell surface is
required for DC maturation. When exposed to UV-inactivated
virus, expression of maturation markers was upregulated in mDC1
(Figure 4D) and pDCs (data not shown). Increased expression
occurred in the complete absence of GFP expression, demonstrat-
ing RSV replication is not required for DC maturation.
Representative data in Figure 4 shows changes in GFP (infection)
and CD86 expression (maturation) for a single donor. Similar
patterns of maturation and inhibition were seen for all phenotypic
markers and in all donors. The pooled data for these treatments of
RSV-infected mDC1 are summarized in Table 1. Although
upregulation of maturation markers was triggered by exposure to
UV-inactivated rgRSV, the level of maturation marker expression
was generally less than that seen with exposure to live rgRSV
(Table 1). These data suggest that RSV induces DC maturation
both by interaction of virus particles with the cell surface and by
processes associated with viral entry and/or replication.
RSV infection induces different patterns of cytokine and
chemokine production in mDC1, mDC2, and pDCs
Secretion of cytokines and chemokines are also triggered as a
result of DC activation. Production of RANTES, IL-6, IL-8, MIP-
1a, MIP-1b, and IFN-a by RSV-exposed DCs were examined by
traditional sandwich ELISA (Figure 5 and Table S3). Our
preliminary studies of RSV infection of primary mDC1 and
pDC demonstrated no detectable production of IFN-b, IFN-c,
TNF-a, or IL-12. Therefore, these cytokines were not examined in
Figure 1. Frequency and RSV infection rates of primary mDC1,
mDC2 and pDC. Panel A – Primary pDC and mDC1 were sequentially
isolated from elutriated human monocytes in the first cohort of donors
by magnetic selection and infected with rgRSV (moi=5) as described in
the Materials and Methods. The percentage of infected (GFP+) cells was
determined 18–24 hrs post-infection for mock-infected cells (N, n=27),
mDC1 (&, n=27), and pDCs (m, n=20). Relative to mock-infected cells,
significantly more mDC1 and pDCs are GFP+ (p,0.0001 and p=0.007,
respectively). Panel B – In a second cohort of donors, pDC, mDC1, and
mDC2 were sequentially isolated from elutriated monocytes. The cell
subsets were counted and frequency within the elutriated monocytes
calculated. Panel C – Following magnetic selection and overnight
resting, mDC1, mDC2, and pDC were exposed to live rgRSV (moi=5).
Twenty-four hours after infection, uninfected and infected cells were
fixed and analyzed by flow cytometry. Data are represented as the
percentage of GFP+ cells within live DCs. For panels B and C, N=11
donor samples with 1 donor present for 2 separate visits. * =
significantly different from mDC1 and mDC2, p,0.05.
doi:10.1371/journal.pone.0016458.g001
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single donor, primary mDC1 and pDC were isolated and moDC and macrophages were generated as detailed in the Materials and Methods. Panel A –
Isolated mDC1 (shown above) and pDC (not shown here) were infected with rgRSV (moi=5). RSV infection (GFP expression) and DC maturation
(CD83, CD86, and CD209 expression) were evaluated after overnight incubation with rgRSV. Dot plot results for mDC1 from a single representative
donor (of 15) are shown above. Panel B – mDC1 and pDCs were exposed to live RSV, and DC maturation was examined 18–24 hrs later. Expression of
each maturation marker in mDC1 and pDCs is shown, normalizing the mean fluorescence intensity (MFI) in RSV-exposed DC cultures to mock-
infected DCs for the same donor. N=16 for mDC1 and 8 for pDCs. Panel C – After overnight exposure of primary mDC1, moDC, and macrophages
from a single donor to live rgRSV, DC maturation was examined by flow cytometric analyses of CD86 and CD40 expression. A representative
maturation profile is shown with similar maturation patterns observed in 5 independent donors.
doi:10.1371/journal.pone.0016458.g002
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cytokine in most donors, although increases in IL-6 levels of RSV-
exposed cells were not significantly different than levels in mock-
treated cells for any DC subset (Table S3). In contrast, all other
cytokines were significantly increased in RSV-exposed mDC1
(Figure 5). RANTES and MIP-1b levels in RSV-exposed mDC2
were significantly greater than in mock-treated cells, while
increases in MIP-a and IFN-a were not (Figure 5 and Table
S3). RSV infection of mDC2 produced little increase above basal
production of IL-8 in most donors (Figure 5 and Table S3). While
production of all cytokines were increased in pDCs following RSV
exposure, only IL-8 levels in RSV-exposed pDC were significantly
greater than in mock-treated cells (Figure 5, p=0.002).
When comparing the induction of cytokine and chemokine
responses across DC subsets, only IL-8 production showed
significant differences. IL-8 production by pDCs was significantly
Figure 3. Maturation of RSV-exposed mDC1, mDC2, and pDCs. DC subsets were isolated and infected as detailed in Figure 1. Twenty-four
hours after RSV exposure, cells were stained for expression of surface maturation markers and analyzed by flow cytometry. Data are represented as
the mean channel fluorescence of RSV-exposed DCs normalized to the mean channel fluorescence of mock-infected cell controls, gating on all live
DCs (panel A) or on live GFP+ cells only (panel B). Actual (non-normalized) MFI values for each donor are detailed in Table S3. N=11 with 1 donor
present for 2 separate visits. * = significantly different from mock-infected cell of the same type; ** = significantly different from mDC1 and mDC2;
# = significantly different comparing total cells and GFP+ cells only. p,0.05.
doi:10.1371/journal.pone.0016458.g003
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p=0.009 and 0.0006, respectively). Additionally, increases in
mDC1 IL-8 levels were greater than in mDC2 (p=0.039).
Differences in the induction of RANTES, MIP-1a, MIP-1b, and
IFN-abetween DC subsets were not statistically significant. While
IFN-a was induced in all DC subsets, the absolute concentrations
of IFN-a secreted by mDC1 and mDC2 were markedly lower than
levels in pDC from the same donor (Table S3). Cytokine
concentrations from individual donors for each uninfected and
infected DC subset are listed in detail in Table S3.
Analyses of cytokine, chemokine, and growth factor production
were extended by multiplex analysis (Figure 6). The panel of
analytes included IL-8, IL-10, IL-12, G-CSF, M-CSF, MIP-1a,
MIP-3b, monocyte chemoattractant protein-1 (MCP-1), macro-
phage-derived chemokine (MDC), matrix metalloproteinase-9
(MMP-9), tissue inhibitor of MMP 1 (TIMP-1), TIMP-2,
thrombopoietin (TPO), thrombomodulin (TM), and tumor
necrosis factor receptor type 2 (TNF-RII). IL-12 production was
not detected in any uninfected or RSV-infected sample from any
donor (Table S3). When production was normalized to uninfected
cells of the same subset, levels of most other analytes were
significantly increased (Figure 6 and Table S3). TPO, M-CSF, and
TM were generally not detectable in uninfected mDC1, mDC2, or
pDC, but were induced following RSV exposure, so the protein
concentration defined as the limit of detection was used for the
mock-infected value in normalization of these chemokines. In
RSV-exposed mDC1, IL-8, IL-10, G-CSF, M-CSF, MIP-1a,
MIP-3b, MCP-1, MDC, TIMP-1, TIMP-2, TPO, and TNF-RII
were significantly increased relative to mock-treated cells while
changes in MMP-9 and TM production were not significantly
different (Figure 6 and Table S3). In contrast, RSV-exposed
mDC2 exhibited lower fold increases in production with
significant differences occurring only in G-CSF, IL-10, MCP-1,
MIP-1a, TIMP-2, TPO, and M-CSF (Figure 6). While the fold-
change in cytokine and chemokine levels in mDC2 were often
lower than the normalized values in mDC1, mDC2 have
inherently higher levels of baseline production (Table S3 and
Figure S1). Therefore, on the basis of absolute values, RSV-
exposed mDC2 had comparable post-infection cytokine and
chemokine levels as mDC1 (Table S3). As with mDC1, RSV
induced marked increases in most of the measured cytokines and
chemokines in pDCs with statistically significant differences
observed in IL-8, IL-10, G-CSF, M-CSF, MIP-1a, MCP-1,
MDC, TIMP-1, TIMP-2, TPO, TM, and TNF-RII (Figure 6 and
Figure 4. RSV infection of mDC1 requires divalent cations and viral replication, but maturation does not require replication. mDC1
were mock infected (panel A), or exposed to live RSV (panel B), RSV treated with 0.05 M EDTA (panel C), or UV-inactivated RSV (panel D). Equivalent
viral particles (moi=5 of live virus) were used for each RSV exposure. Twenty-four hours after virus exposure the cells were stained for maturation
markers (CD83, CD86, CD209) and analyzed by flow cytometry. GFP and CD86 expression is shown in a representative donor (of 8) in which both
EDTA-treated and UV-inactivated RSV were used. Data for all donors are summarized in Table 1.
doi:10.1371/journal.pone.0016458.g004
Table 1. Maturation of mDCs After RSV Infection.
# of
Donors CD83 CD86 CD209
Uninfected 27 1601 601 60
rgRSV 28 1.9860.76
a 2.3861.12
a 1.6060.62
a
EDTA-treated rgRSV 8 1.3460.47
b 1.3360.73
b 0.9960.24
b
UV-inactivated rgRSV 6 1.2160.32
b 1.7960.46
a 1.2760.30
Data are represented as the fold increase in mean channel fluorescence (MFI)
relative to the uninfected cells for each individual donor.
asignificantly different than uninfected cells, p,0.05.
bsignificantly different than rgRSV cells, p,0.05.
doi:10.1371/journal.pone.0016458.t001
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significantly increased by RSV exposure of pDCs.
In all three DC subsets, two distinct patterns of induction were apparent.
Most analytes had a relatively low level of induction (#10-fold) while a
small group of analytes (including MCP-1, TIMP-2, and M-CSF) had high
levels (.10-fold) of induction (Figure 6). While the general pattern of ‘‘low’’
and ‘‘high’’ responses occurred for the same analytes across the DC subsets,
cell-specific patterns of cytokine and chemokine production were observed
within these groups. TIMP-1 production was generally greater in pDC
than in mDC1 or mDC2. In contrast, increases in TIMP-2 and M-CSF
were similar in pDC and mDC2 and were greater than those seen in
mDC1. MCP-1 levels were greateri nm D C 1t h a ni nm D C 2o rp D C .
Additionally, while changes in MMP-9 levels were not statistically
significant comparing mock-treated and RSV-exposed DCs for each
subset, significant differences were observed between the primary DC
subsets with pDCs having greater increases in expression (normalized level
=1.34) relative to mDC1 (0.97) and mDC2 (0.78). Absolute cytokine and
chemokine levels from uninfected and infected cultures for each donor are
listed in Table S3.
Identification of potential cell-specific response patterns
in RSV-exposed DCs
Variations were observed between donors in the rates of RSV
infection (i.e. GFP expression), in the upregulation of maturation
markers, and in cytokine and chemokine production. Therefore,
the data were analyzed by Spearman’s rank order correlation to
determine if associations exist between the susceptibility to RSV
infection, the magnitude of DC maturation, or the production of
cytokines after RSV exposure. These analyses are detailed in
Table S4. Correlation analyses demonstrated no correlation
between infection rates and expression of maturation markers or
cytokine production in mDC1 and pDC with only a weak
correlation between pDC infection rates and TIMP-1 production
observed. When upregulation of maturation markers and
cytokine/chemokine production were compared, positive correla-
tions were found between CD86 and CD40 expression on mDC2
and between CD86 expression and MMP9 production in pDCs.
In contrast, CD86 expression on mDC1 was negatively correlated
with production of MIP-1b while CD209 expression on mDC2
was inversely associated with M-CSF production.
Correlation analyses of cytokine and chemokine production
within each DC subset were also performed and are detailed in
Tables S5, S6, and S7 for mDC1, mDC2, and pDC, respectively.
Comparison of the correlations between each DC subset suggests a
potential ‘‘myeloid signature’’ of cytokine and chemokine
production with the strong positive correlations in mDC1 and
mDC2 between IL-6, IL-8, and G-CSF and TIMP-1 and TPO
(denoted by black framed values) while no correlation is found
between these cytokines in RSV-exposed pDCs. Unique to
Figure 5. Cytokine and chemokine production as measured by standard sandwich ELISA. DC subsets were isolated and exposed to RSV
as described in Figure 1. Twenty-four hours after RSV infection, the culture supernatants were removed and frozen. Subsequently, cytokine and
chemokine levels were measured by sandwich ELISA according to kit protocols. Data represent production levels of RSV-exposed DCs normalized to
uninfected DCs of the same cell type. Actual (non-normalized) cytokine concentrations for each donor are detailed in Table S3. N=11 with 1 donor
present for 2 separate visits. * = significantly different from mock-infected cells of the same type; ** = significantly different from mDC1 and mDC2;
# = significantly different from mDC1 only. p,0.05.
doi:10.1371/journal.pone.0016458.g005
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and MIP-1b. MMP9 production was found in strong positive
correlation to production of IL-6, IL-8, G-CSF, TIMP-1, TPO,
and MDC in mDC2 (red framed values). In pDCs only were
MMP9, TIMP-1, and TPO associated with MIP-1a production
and M-CSF with IL-6, G-CSF, and MMP9, although the negative
correlations were weak (0.01,p,0.05). This report is the first
examination of MMP9, TIMP-1, and TIMP-2 production in
Figure 6. RSV-induced of cytokine, chemokine, and growth factor production measured by multiplex analyses. Cytokine and
chemokine levels were measured by multiplex assay. Data represent production levels of RSV-exposed DCs normalized to uninfected DCs of the same
cell type. Actual (non-normalized) cytokine concentrations for each donor are detailed in Table S3. N=9 unique donors. * = significantly different
from mDC1 only; ** = significantly different from mDC1 and mDC2, p,0.05.
doi:10.1371/journal.pone.0016458.g006
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TIMP-1 with the production of a number of cytokines potentially
suggests functional roles for these mediators in RSV-induced
immunity. Furthermore, identification of distinct associations of
these cytokines among the DC subsets and the lack of correlation
between TIMP-2 with any other cytokine (despite high levels of
TIMP-2 production) may indicate RSV- and cell-specific effects
for the chemokines within mDC1, mDC2, and pDC subsets.
Further examination of such cytokine and chemokine production
profiles may definitively identify subset-specific patterns which can
subsequently reveal distinctive functional roles for individual DC
subsets during RSV infection.
Discussion
Dendritic cells are critical for initiation and imprinting of
immune responses. Both mDCs and pDCs are recruited to the
respiratory tract in virally-infected infants, and differences in DC
recruitment and function have been observed in children who
experienced bronchiolitis compared to mild upper respiratory
infection or in infants infected with RSV compared to those
infected with influenza [41–43]. RSV is often the first viral
infection in life. Because the initial exposure to RSV antigens
during primary infection of infants may play a role in establishing
susceptibility to subsequent reinfection, it is important to
understand the effects of RSV exposure on the maturation and
function of primary human mDCs and pDCs. In this report we
have used GFP-expressing RSV A2 and multi-parameter flow
cytometric analyses to examine the impact of RSV infection on
primary mDCs and pDCs. We demonstrate that both mDCs and
pDCs are infected with RSV in a divalent cation-dependent
manner. While variation in infection rates among donors was
observed, mDC1 and mDC2 infection rates were greater than that
of pDCs. Additionally, exposure to RSV induced maturation of
both infected and uninfected mDCs and pDCs as previously
observed in moDCs [33]. Similarly, RSV stimulated the
production of cytokines from mDCs and pDCs. This was
particularly true for RANTES secretion (Figure 5) which has not
been previously reported from RSV-infected primary DCs. In
contrast, IL-10, IL-12, IFN-c, and TNF-a have been reported in
RSV-infected cord-blood-derived DCs and moDCs [29,34,37–
39], but no IL-12 and only very low levels of IL-10 were detected
in RSV-exposed primary mDCs or pDCs in this study (Figure 6
and Table S3). A caveat is that we used a recombinant virus based
on the A2 strain of RSV. A prior report using RSV Long indicated
that mDCs produced IL-12, although the data were not shown
[44]. Additionally, basal levels of IL-6 and IL-8 (i.e. in mock-
infected cells) were higher than expected. This may reflect some
level of cellular activation during monocyte elutriation. Alterna-
tively, this may also represent low level acute activation resulting
from the very short (overnight) incubation of the isolated DC
subsets on plastic in the presence of GM-CSF or IL-3 – which has
been shown to be sufficient to initiate DC activation and induces
formation of dendritic processes visible by light microscopy (data
not shown). While these cytokines are present, there is not
significant surface expression of traditional activation markers such
as CD80, CD86, and CD40. Therefore, if activation during the
processing phase has occurred, it is minimal.
UV-inactivated virus was able to induce maturation without
viral replication, although increases in maturation markers and
cytokine production did not attain the maximal levels induced by
live RSV infection of the same donor (Table 1). These data
indicate RSV binding may be sufficient to mediate at least partial
DC activation. However, divalent cations were required for both
infection and maturation, suggesting the interaction of RSV
surface proteins with C-type lectins on DCs transmits signals that
affect maturation independent of infection. While not identified by
reconstitution experiments in our study, the divalent cation
critically required for RSV infection of DCs presumably is Ca
2+
which has been demonstrated to be necessary for RSV infection of
[57] and syncytium formation in HEp-2 cells [58] and for RSV F
and G binding to surfactant proteins [59,60]. It is clear from the
pDC data that infection causes a different level of activation that is
distinct from just binding of surface receptors. In pDCs, CD40
expression in 5 donors (of 11) and CD209 expression in 7 donors
(of 11) is decreased in RSV-exposed cells (normalized value ,1).
This is in striking contrast to the expression of maturation markers
on productively infected, GFP+ pDCs where marked increases in
CD40 and CD209 expression and significantly higher expression
of CD86 relative to total RSV-exposed pDCs are observed
(Figure 6). This is similar to findings of Shingai et. al. in which
RSV inhibition of IFN-b production in transfected HEK293 and
moDCs was shown to occur in two phases, one dependent upon
virus-cell contact with infection and another interaction mediated
by soluble RSV G [61]. These findings may explain why pDCs are
less likely to be infected, but more dependent on infection to
trigger the maturation process. The decrease in pDC infectivity
may also reflect an inhibition of replication due to the increased
production of IFN-a observed in these cells. Therefore, we suggest
a two-step process is involved in maximal activation of primary
human DCs by RSV – one which is triggered by the binding of
viral particles and a second initiated by viral entry and/or
replication, and future studies of RSV and DC interactions should
attempt to discriminate the signaling events induced by attach-
ment and binding from the events associated with entry and viral
replication.
Studies have shown a lack of DC activation following exposure
to UV-inactivated RSV [31,33,34,37,39]. However, our data
(Figure 4) and several previous reports [28,29,40,44,62] demon-
strate UV-inactivated RSV can induce DC activation or impact
DC function in the absence of viral replication. UV irradiation can
induce structural changes resulting in loss of protein function
[63,64] with sensitivity to UV inactivation varying among different
proteins [65]. As UV inactivation may disrupt disulfide cysteine
bonds [66], the conserved cysteine noose of RSV G and the
cysteine-rich domain between the heptad repeats of RSV F
potentially make the two major surface viral glycoproteins
particularly sensitive to UV treatment. Thus, the disparate reports
on DC activation by UV-exposed RSV may be explained by the
multiple methods used to inactivate the virus.
While levels of maturation markers such as CD83 and CD86
increased on both infected and uninfected mDCs and pDCs
(Figures 2 and 3), CD40 expression was upregulated only on RSV-
infected pDCs (Figure 3). The failure to upregulate CD40 on
mDCs and uninfected pDCs may be relevant to the subsequent
ability of RSV-exposed DCs to initiate or expand virus-specific
adaptive immunity. CD40 is critical for co-stimulation and
activation of antigen-specific T and B cells [67]. CD40 expression
on DCs may also influence activation and function of NK and
NKT cells [68,69] which can impact RSV pathogenesis in the
mouse model [70].
Potential roles for MMP-9 and its inhibitor TIMP-1 in RSV
pathogenesis have been reported. RSV was shown to induce
MMP-9 expression in cultured epithelial cell lines and to be
involved in syncytium formation by infected cells [57]. Further-
more, transfection of cells with TIMP-1 prior to RSV infection
reduced syncytium size [57]. These studies were extended by
Elliott et al. with the demonstration of MMP-9 and TIMP-1 in the
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PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e16458nasopharyngeal secretions of infants infected with RSV or
parainfluenza virus with levels correlating with disease severity
as assessed by hypoxia [71]. However, while MMP-9 and TIMP-1
were produced by RSV-infected transformed cells lines (e.g.
A549), they were not detected in RSV-infected primary normal
human bronchial epithelia (NHBE). TIMP-2 production was not
detected in either paramyxovirus-infected cell lines or NHBE.
While RSV infection of DCs did not increase MMP-9 production
(Figure 6), we demonstrate for the first time that RSV infection
induces marked increases of TIMP-2 and (lower levels of increases
in TIMP-1) in all DC subsets. Thus, DCs may be an important
source of TIMP-2, and could thereby contribute to the regulation
of MMP-9 in the respiratory tract.
Innate immunity at mucosal surfaces such as the lung is highly
complex and flexible, maintaining the balance between tolerance
and inflammation while under constant insult from environmental
factors. This may be reflected in the diversity of DC phenotypes
found at the mucosa of specific tissues and within different
compartments of a single organ [72,73]. DC precursors and
immature DCs in the lung respond to factors secreted by resident
epithelial and innate cells, resulting in differentiation and activation
[72–76]. Monocytes residing in the respiratory tract have been
suggested as a local precursor for pulmonary DCs, particularly
maintaining homeostatic balance [72,73,75]. Studies in mice have
demonstrated that blood monocytes subsets have the potential to
differentiate into distinct subsets of respiratory tract DCs [77,78].
However, these studies do not exclude a role for blood-derived DCs
in pulmonary inflammation, and the rapidity of DC infiltration in
response to local antigen challenge [79] suggests that recruitment of
DCs from blood can be a rich source of antigen presenting cells.
Thus, achieving the level of functional and phenotypic DC diversity
in distinct compartments of the respiratory tract under normal
versus inflammatory conditions may require both differentiation of
local monocytes and recruitment from the blood of immature or
precursor mDCs and pDCs.
In this detailed analyses of primary mDC1, mDC2, and pDC
from a relatively large number of donors we demonstrate that
RSV has distinct effects on maturation and cytokine production in
each subpopulation of primary human DCs. All RSV-exposed
DCs have increased CD86, but only RSV-infected pDCs
upregulate CD40 and CD209. mDC1 express lower levels of
TIMP-2 and M-CSF, but have greater production of MCP-1 after
RSV exposure than mDC2 or pDC. IL-8 production and CD40
expression on RSV-infected mDC2 was minimal, but levels of
TIMP-2 and M-CSF were greater than in mDC1 and comparable
with pDC production. Furthermore, our data indicate that TIMP-
2 is produced by RSV-exposed DCs, suggesting a potential role for
DCs in regulating the effects of MMPs induced during RSV
infection. Understanding these interactions is important for
defining new therapeutic approaches for severe RSV disease.
Future studies should take into account potential differences in
RSV strain-specific interactions with human DCs, which would
require construction of additional molecular clones of RSV or
alternative methods for detecting individual RSV-infected cells.
Considering that RSV is often the first virus encountered by
neonates, defining the role of RSV in DC biology may be
important for understanding disease pathogenesis and may have
broader implications for lung development and maturation of the
human immune system.
Supporting Information
Figure S1 Basal levels of cytokine, chemokine, and
growth factor production measured by multiplex anal-
yses. mDC1, mDC2, and pDC were isolated and exposed to
RSV as described in Figure 3. Twenty-four hours after RSV
infection, the culture supernatants were removed and frozen.
Subsequently, cytokine and chemokine levels were measured by
multiplex assay. Data represent basal levels of mock-infected DCs
as protein concentration in pg/ml standardized to 10
5 cells. N=9
unique donors.
(TIFF)
Table S1 Phenotype and Functional Comparison of
Primary Human DC Subsets. The standard cell surface
markers used for differentiation of mDC1, mDC2, and pDC and
the main functions of each DC subset are detailed.
(TIFF)
Table S2 Multiparameter Flow Cytometry Panels.
(TIFF)
Table S3 Individual Values for Donor Set #2. The values
for infection rates, mean fluorescence intensity of cell surface
markers, and levels of cytokines produced are shown for mock-
and RSV-infected mDC1, mDC2, and pDC for each individual
donor. Cytokine values represent the concentration of each
cytokine in pg/ml at 1610
5 cells per tube after overnight
infection. NT = not tested. ND = not detected.
(TIF)
Table S4 Correlation Analyses (Spearman’s Rank Or-
der) of RSV Infection Rates with Maturation and
Cytokine/Chemokine Production. For the RSV-exposed
DCs, infection rates were correlated with expression of maturation
markers and with cytokine and chemokine production for each
donor. Maturation marker expression was also correlated with
cytokine and chemokine levels for each donor. These analyses
were performed using Spearman’s rank order test of correlation.
Strong positive correlations are defined as r.0 and p,0.01 and
are denoted by bold red values in gray shaded boxes while weak
positive correlations are defined as r.0 and 0.01,p,0.05 and are
denoted by bold red values. Similarly, strong negative correlations
are defined as r,0 and p,0.01 and are denoted by bold blue
values in gray shaded boxes while weak negative correlations are
defined as r.0 and 0.01,p,0.05 and are denoted by bold blue
values.
(TIF)
Table S5 Correlation Analyses (Spearman’s Rank Or-
der) of mDC1 Cytokine/Chemokine Production. For each
individual donor (data detailed in Table S3), cytokine and
chemokine production by RSV-exposed mDC1 were correlated
to each other. These analyses were performed using Spearman’s
rank order test of correlation. Strong positive correlations are
defined as r.0 and p,0.01 and are denoted by bold red values in
gray shaded boxes while weak positive correlations are defined as
r.0 and 0.01,p,0.05 and are denoted by bold red values.
Similarly, strong negative correlations are defined as r,0 and
p,0.01 and are denoted by bold blue values in gray shaded boxes
while weak negative correlations are defined as r.0 and
0.01,p,0.05 and are denoted by bold blue values.
(TIF)
Table S6 Correlation Analyses (Spearman’s Rank Or-
der) of mDC2 Cytokine/Chemokine Production. For each
individual donor (data detailed in Table S3), cytokine and
chemokine production by RSV-exposed mDC2 were correlated
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rank order test of correlation. Strong positive correlations are
defined as r.0 and p,0.01 and are denoted by bold red values in
gray shaded boxes while weak positive correlations are defined as
r.0 and 0.01,p,0.05 and are denoted by bold red values.
Similarly, strong negative correlations are defined as r,0 and
p,0.01 and are denoted by bold blue values in gray shaded boxes
while weak negative correlations are defined as r.0 and
0.01,p,0.05 and are denoted by bold blue values.
(TIF)
Table S7 Correlation Analyses (Spearman’s Rank Or-
der) of pDC Cytokine/Chemokine Production. For each
individual donor (data detailed in Table S3), cytokine and
chemokine production by RSV-exposed pDC were correlated to
each other. These analyses were performed using Spearman’s rank
order test of correlation. Strong positive correlations are defined as
r.0 and p,0.01 and are denoted by bold red values in gray
shaded boxes while weak positive correlations are defined as r.0
and 0.01,p,0.05 and are denoted by bold red values. Similarly,
strong negative correlations are defined as r,0 and p,0.01 and
are denoted by bold blue values in gray shaded boxes while weak
negative correlations are defined as r.0 and 0.01,p,0.05 and
are denoted by bold blue values.
(TIF)
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